sglt2 glp-1 news Complementary Yet Distinct Roles of Receptor Agonists and Inhibitors in Cardiovascular Risk Reduction Combined SGLT2 and GLP-1 therapy

What is Lipo-C? Lipo-C is a compounded injectable that combines lipotropic agents (compounds that move fat out of the liver) with amino acids and cofactors that support fat metabolism and energy

The Precision Peptide Genetic Test reveals variants in GLP1R, GIPR, FTO, and MC4R pathwaysfactors that should be interpreted with a qualified healthcare provider alongside clinical data to inform your GLP-1 treatment conversation

Such risks arise due to the delayed gastric emptying effects of GLP-1 medications, which can leave residual food in the stomach, increasing the potential for aspiration pneumonia

Intramedullary melanotic schwannoma: a rare presentation of a rare tumor

Once you arrive at our clinic, you will meet with Dr

Diabetes2004 Aug;53(8):1959-65